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Purpose: To report the design and imaging methodology of a photoacoustic scanner dedicated to
imaging hemoglobin distribution throughout a human breast.
Methods: The authors developed a dedicated breast photoacoustic mammography (PAM) system
using a spherical detector aperture based on our previous photoacoustic tomography scanner. The
system uses 512 detectors with rectilinear scanning. The scan shape is a spiral pattern whose radius
varies from 24 to 96 mm, thereby allowing a field of view that accommodates a wide range of breast
sizes. The authors measured the contrast-to-noise ratio (CNR) using a target comprised of 1-mm
dots printed on clear plastic. Each dot absorption coefficient was approximately the same as a 1-mm
thickness of whole blood at 756 nm, the output wavelength of the Alexandrite laser used by this
imaging system. The target was immersed in varying depths of an 8% solution of stock Liposyn II-
20%, which mimics the attenuation of breast tissue (1.1 cm−1). The spatial resolution was measured
using a 6 μm-diameter carbon fiber embedded in agar. The breasts of four healthy female volunteers,
spanning a range of breast size from a brassiere C cup to a DD cup, were imaged using a 96-mm
spiral protocol.
Results: The CNR target was clearly visualized to a depth of 53 mm. Spatial resolution, which was
estimated from the full width at half-maximum of a profile across the PAM image of a carbon fiber,
was 0.42 mm. In the four human volunteers, the vasculature was well visualized throughout the breast
tissue, including to the chest wall.
Conclusions: CNR, lateral field-of-view and penetration depth of our dedicated PAM scanning
system is sufficient to image breasts as large as 1335 mL, which should accommodate up to
90% of the women in the United States. © 2013 American Association of Physicists in Medicine.
[http://dx.doi.org/10.1118/1.4824317]
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1. INTRODUCTION
Mammography is the current gold standard for screening
asymptomatic women for breast cancer and has been proven
to decrease mortality.1–3 However, this technology has limi-
tations. In women with dense breasts, mammography has not
been proven as sensitive as in the population of women with
nondense breasts. In reaction to this problem, researchers are
exploring optical imaging of the breast with lasers as a way
to eliminate the lesion obscurity resulting from overlapping
breast tissue prevalent in women with dense breasts.4
In optical imaging of the breast, hemoglobin is the primary
component that is evaluated.
Hemoglobin is a strong optical absorber in the near in-
frared, and its presence in breast masses correlates strongly
with angiogenesis and elevated micro-vessel density, which
are consistent biomarkers of malignancy.5 It has been demon-
strated that when breast cancers reach approximately 1–2 mm
(106 cells), they are no longer adequately nourished by diffu-
sion, and hypoxia ensues.6 Hypoxia induces expression of cy-
tokines like vascular endothelial growth factor (VEGF), lead-
ing to the creation of tumor vessels that are characterized
by their disorganized structure and leaky capillaries.7 Aver-
age levels of hemoglobin are reportedly higher in malignant
masses relative to “normal” breast tissues.8
The absorption coefficient of hemoglobin in whole blood
(150 gm/L) is ∼0.62 cm−1 at 756 nm,9 whereas hemoglobin-
free breast tissue parenchyma has a reported absorption coef-
ficient of only 0.04–0.05 cm−1 at the same wavelength, and
the effective scattering coefficient of all breast tissue is be-
tween 8 and 12 cm−1.10, 11 Of note, the resulting effective op-
tical attenuation coefficient for an average breast is therefore
∼1.0–1.3 cm−1, which is only slightly greater than that re-
ported at mammographic x-ray energies (0.5–0.8 cm−1),12 yet
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the differential contrast between hemoglobin-rich (tumors,
blood vessels) and hemoglobin-deprived (fat, glandular) tis-
sue is significantly greater than the differential contrast be-
tween tumor and surrounding breast tissue at x-ray energies.
A laser-based optoacoustic imaging system (LOIS) for de-
tecting breast cancer was proposed over a decade ago by
Oraevsky et al.13 Spatial resolution within the imaging plane
is reported to be 0.5 mm, but cross-plane spatial resolution is
relatively poor. Another common approach to photoacoustic
imaging is to incorporate a pulsed light source into a con-
ventional medical ultrasound probe, e.g., the OPUS (optoa-
coustic plus ultrasound) system developed by Haisch et al.14
Dynamic acquisition is possible, too, albeit over a single
imaging plane. The Twente Photoacoustic Mammoscope, in-
troduced by Manohar et al. in 2004, produces 3D images over
a 90-mm field of view.15 Scan time is reported to be 30 min
and spatial resolution is 2.3–3.9 mm.
Our specially designed, dedicated 3D Photoacoustic Mam-
mography system uses a low-power, FDA-approved infrared
laser and standard medical ultrasound detectors in a unique
configuration to image the breast while the patient is prone on
a cushioned table.
2. METHODS
The design of our dedicated photoacoustic mammography
(PAM) scanning system is derived from our previous work.
We demonstrated that hemoglobin could be imaged to a depth
of 40 mm in the breast over a 64-mm-wide field of view with
submillimeter spatial resolution using infrared light.16 The
PAM scanner, pictured in Fig. 1, consists of an exam table
(T) upon which a patient lies prone, placing one breast in a
spherically shaped cup (C) thermoformed from a 0.020” thick
sheet of polyethylene terephthalate (PETG). This cup was op-
tically clear and displayed >70% acoustic transmission over
± 40◦ at 2 MHz. A small amount of clean water is placed in
the breast cup of the scanner along with the breast prior to
FIG. 1. Photograph of PAM scanner showing the exam table (T) and the
breast positioning cup (C), below which is located the hemispherical detector
array.
FIG. 2. Drawing showing the hemispherical array (A) mounted on a two-
axis translational stage (XY). The hemispherical array and an extension (E)
are filled with degassed RO water. Laser light is fed from the bottom of the
array via an articulating arm (not shown) through a negative lens that diverges
the laser light (L) to a diameter of ∼60 mm at the breast surface.
imaging to provide acoustic coupling between the breast and
the breast cup.
Figure 2 shows the hemispherical detector array (A), which
lies beneath the cup of the scanner, affixed to a two-axis trans-
lational stage (XY) whose position is controlled by a pair
of computer-controlled, synchronous motors. The water-filled
detector array is comprised of a hemispherical shell (radius
= 127 mm), machined from ABS plastic, in which are em-
bedded 512 discrete medical ultrasound transducer elements.
Each transducer has a flat active area with a 3-mm diameter.
The center frequency of the 1–3 piezo-composite transducers
is 2 MHz with a 70% bandwidth.
The detector array and a plastic extension (E) to the ar-
ray were filled with reverse osmosis water to provide acous-
tic coupling between the breast cup of the scanner and the
512 transducers. A 7-mm-diameter, pulsed Alexandrite laser
beam (λ = 756 nm, 75 ns @ 300 mJ/pulse) was fed through
an articulating arm that directed the laser beam (L) upward
along the vertical axis of the transducer array as the array was
scanned. A −12 mm diverging lens, placed at the base of the
array, spread the light in a conical fashion to a diameter of
∼60 mm at the surface of the scanner breast cup. The peak
light fluence was measured as ∼10 mJ/cm2 at the center of
the beam, which is less than half of the maximum permissi-
ble exposure (MPE) recommended by the American National
Standards Institute.17
A cutaway of the PAM scanner, which shows the geomet-
ric relationships among the detector array, array extension,
imaging table, and breast cup, is illustrated in Fig. 3. The ar-
ray extension allows the detector array to be scanned laterally
across the breast surface and still maintain water coupling to
the breast. The maximum imaging volume (1335 mL) is de-
fined by the radius of curvature of the breast cup (184 mm),
the width of the aperture through which the breast is placed
(240 mm), and the maximum penetration depth for which
hemoglobin can be visualized. This maximum imaging vol-
ume is denoted by the hatching in Fig. 3.
The detector array was scanned continuously in a spi-
ral pattern within a plane, whose normal lay parallel to the
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FIG. 3. Cut-away view of imaging geometry showing the relationships among the tabletop, breast positioner (spherical cup of .020′′ thick PETG), and the
detector array.
rotational axis of the array, as the laser beam was pulsed at
10 Hz. The spiral patterns we chose were such that the pho-
toacoustic data were acquired at equidistant locations within
a plane, their spacing being the same no matter the size of the
spiral. Thus, larger spirals required more pulses and longer
image-acquisition times than smaller spirals. Examples of two
spiral patterns used for this work are illustrated in Fig. 4. The
smallest spiral had a maximum radius of 24 mm and consisted
of 120 discrete locations; the largest spiral had a radius of 96
mm and consisted of 1920 discrete locations.
Data from each of the 512 transducers were digitized in
parallel after 50 dB of amplification to 12 bits at 20 MHz
for a total of 2048 samples following each laser pulse. Data
were not integrated. Total data acquisition time was anywhere
from 12 s for the smallest spiral to 3.2 min for the largest
spiral. The lateral field of view (FOV) varied from 80 mm
to 240 mm diameter, depending on the exact spiral pattern
chosen.
Three-dimensional PAM images were reconstructed us-
ing a filtered-backprojection algorithm that has been de-
scribed previously.16, 18 We first measured the PA response to
a “point” absorber fabricated from a small spot of ink placed
on the tip of a clear, thin polyethylene thread, which was then
used to calculate a ramp filter function and simultaneously
deconvolve the impulse response of our transducers. After fil-
tering, we backprojected our data over spherical surfaces, the
radii of which were determined from the measured speed of
sound in the water coupling and a second, assumed speed of
sound within the breast (or phantom). We assumed that every-
thing above the breast cup of the scanner was homogeneous
phantom or breast tissue, and everything beneath was water.
The speed of sound in water was calibrated in our laboratory
FIG. 4. Two of the spiral scan patterns used in this report: (a) our smallest spiral (120 locations, radius = 24 mm), and (b) a larger spiral (480 locations, radius
= 48 mm). Note that the spacing between discrete locations is approximately the same for both spirals.
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FIG. 5. A contrast phantom was fabricated by printing 1 mm red dots on a
transparent film and attaching it to a 1-cm-thick disk of PVCp. The dots are
spaced 5 mm apart radially and enclosed by an 80 mm diameter circle. The
absorption of the red dots was equivalent to the absorption of 1 mm blood
thickness at 756 nm.
as a function of temperature, which was recorded during data
acquisition. We chose the sound speed within the breast phan-
tom interactively by visually assessing the “sharpness” of ves-
sels within the breast phantom as the assumed sound speed
above the breast cup of the scanner was varied.
To quantify the contrast-to-noise performance of the PAM
system, we imaged the phantom we developed as shown in
Fig. 5. It consisted of an array of 1-mm “red” dots printed on a
disk of clear plastic with an HP color laser printer and affixed
to a 1-cm thick disk of polyvinylchloride-plastisol (PVCp)
to provide rigidity. The absorbance of the red ink dot at
756 nm was measured with a Genesys 10vis spectrophotome-
FIG. 7. PAM images (24 mm spiral scan) of the contrast phantom through
10, 30, and 53 mm of 8% LiposynII-20%. The contrasts of the three images
have been normalized to one another.
ter as 0.129, which is approximately the same absorbance one
expects for a 1-mm thick sample of blood containing 150 g/L
of oxyhemoglobin.9 Therefore, based on this data, we con-
cluded this to be reasonably equivalent to blood absorption
by a 1-mm-thick blood vessel.
Next, we filled the breast cup of the scanner with an 8%
solution of stock Liposyn II-20%19 to simulate the attenu-
ation of breast tissue (attenuation coefficient = 1.1 cm−1).
The contrast phantom was placed at varying depths within the
Liposyn solution, as shown in Fig. 6. PAM images of the
phantom were acquired using a 24-mm spiral scan with an
acquisition time of 12 s.
PAM images at three depths of Liposyn solution were ac-
quired and are shown in Fig. 7. Both contrast and noise were
measured from those images as a function of depth of Liposyn
solution between the breast cup of the scanner and the loca-
tion of the contrast phantom in the breast cup. The contrast
and contrast-to-noise ratios were then recorded, plotted as a
function of depth of Liposyn solution, and analyzed.
To measure spatial resolution of the PAM scanner, we im-
aged a long filament (6 μm diameter) of graphite fiber em-
bedded in an agar mold, shaped to fit snugly into the scan-
ner breast cup. A photograph of the graphite phantom and a
MIP calculated from a 3D PAM image (48-mm spiral scan,
48 s) are shown in Fig. 8. The full width at half-maximum
(FWHM) of a profile across one of the carbon fibers was used
to estimate the spatial resolution of the PAM system.
FIG. 6. Imaging geometry for measuring contrast and noise using the phantom pictured in Fig. 4 as a function of depth of breast-tissue-mimicking liquid
(8% LiposynII-20%).
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FIG. 8. (a) Photograph of carbon fiber (6 μm diameter) placed in agar mold. (b) MIP of PAM image of carbon-fiber phantom. In making the photoacoustic
image, we placed the dot phantom (Figure 5) atop the agar to keep it from floating, so it is projected on the photoacoustic image of the graphite filament phantom.
[Image of 1 mm dot phantom (Figure 5) provides scale.]
In order to demonstrate that we could maintain good con-
trast, sensitivity, and spatial resolution at the periphery of the
field of view, we translated our contrast phantom laterally
80 mm and scanned with our largest spiral protocol (96 mm,
3.2 min).
Four healthy women volunteers were recruited according
to a protocol approved by the Institutional Review Board of
the University of North Carolina. Each of these volunteers
was greater than 40 years of age and had a normal screen-
ing mammogram within the 12 months prior to PAM imag-
ing. The breast sizes and mammographic breast densities were
recorded for each volunteer. Prior to patient positioning by a
trained mammography research technologist, a few hundred
mL of clean water were placed in the imaging cup of the scan-
ner and the patient was positioned prone on the exam table,
placing her left breast approximately in the center of the cup
of the scanner. The patient’s right arm was positioned in an
arc above her head and her left arm was placed along her left
side (left “swim” position). Additional clean water was added
to fill to the top of the cup of the scanner as needed. The pa-
tient was then instructed to lie still and breathe normally dur-
ing the 3.2 min breast scan/data acquisition. A 96-mm spiral
was used for data acquisition. After imaging the left breast,
the right breast was positioned, as above, and imaged in an
identical fashion, interchanging the positions of the left and
right arm (right “swim” position).
Three-dimensional PAM images of each breast for each
volunteer were reconstructed on 1024 × 1024 × 300 vox-
els (.25 mm on a side) using filtered backprojection. To
compensate for the exponential loss of PAM contrast as a
function of the thickness of breast tissue, the recon-
structed images were further processed by applying a depth-
dependent, exponential scaling, eαz, where z is distance (cm)
along the anterior-posterior (AP) axis, and α is a constant
that could be adjusted retrospectively. Reconstruction took
approximately 25 min using three NVIDIA K20 GPU cards.
In addition, we calculated maximum-intensity projections
(MIPs) in both the medial-lateral (ML) and the coronal pro-
jections for image display.
3. RESULTS
The photoacoustic contrast for the center “dot” of our con-
trast target (Fig. 7) was measured and plotted as a function
of the depth of the 8% Liposyn II-20% solution. The result
is plotted in Fig. 9(a) and displays exponential decay with
FIG. 9. (a) Contrast as a function of depth in Liposyn II solution. The data,
when fit to an exponential, revealed an effective attenuation coefficient of
1.1 cm−1. (b) Contrast-to-noise ratio (CNR) was calculated from images
such as those displayed in Fig. 7. The CNR was approximately constant
(∼200) for depths < 30 mm and was limited by streak noise, which is propor-
tional to contrast. For greater depths, the system electronic noise [∼1 unit on
Fig. 9(a)] began to degrade the CNR.
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FIG. 10. PAM image of contrast phantom displaced 80 mm laterally from
the center of the breast cup. To capture this image, the radius of the spiral
scan was increased to 96 mm (1920 locations). The phantom was visualized
clearly at the periphery of the image volume.
depth. The noise was calculated as the standard deviation
within a small region of the background in the contrast target.
This “noise” estimate was recorded and used to calculate the
contrast-to-noise ratio (CNR), which is plotted in Fig. 9(b).
We could not collect data for depths >53 mm due to the finite
depth of the breast-restraining cup of the scanner.
The spatial resolution was estimated from a plot across
one filament of the graphite fiber phantom [Fig. 8(b)]. The
full width at half-maximum of the plot was 0.42 mm. This
resolution did not vary much with orientation of the graphite
filament, demonstrating nearly isotropic spatial resolution.
The lateral field of view was measured as 24 cm as indi-
cated from the visibility of the contrast phantom placed at the
edge of our field of view (Fig. 10).
Maximum intensity projections from the four healthy vol-
unteer bilateral PAM exams are shown in Figs. 11 and 12.
Vessels were clearly visualized back to the chest wall in all
four volunteers with breast sizes that ranged from C to DD
cups.
4. DISCUSSION
The results from this study indicate that we can use a ded-
icated photoacoustic imaging device to evaluate hemoglobin
distributions in healthy human breast tissue. Initially, we be-
gan our research with the intent of adapting a preclinical pho-
toacoustic tomography (PAT) scan design, initially used with
animal models, to image the human breast.20 However, the
preclinical breast PAT scanner had a limited field of view
(relative to a human breast), but high enough spatial resolu-
tion (0.2–0.3 mm) to visualize the vasculature in a small mam-
mal. Penetration depth of 1–2 cm was sufficient for imaging
mice, but insufficient for imaging the human breast. Lesser
spatial resolution and greater tissue penetration is required
in clinical breast imaging, where the vasculature has a range
of diameters of 0.5–2.0 mm, but tissue penetration must ap-
proach 5 cm. Therefore, in our dedicated breast PAM system,
we opted to trade spatial resolution for increased contrast sen-
sitivity. This was done by reducing the center frequency of our
ultrasound transducers from 5 to 2 MHz. In addition, greater
optical fluence was used to increase the dynamic range of the
system.
The greatest challenge, however, was to find a way to in-
crease the field of view of the system dramatically, which was
ultimately limited by the angular sensitivity of our circular
transducers, without sacrificing contrast sensitivity. Choosing
FIG. 11. Maximum intensity projections in the medial-lateral (ML) projection of bilateral PAM exams of four healthy volunteers with known mammographic
breast density and brassiere cup size (back-to-back images: left breast on right, right breast on left as is normally presented clinically for x-ray mammograms):
(1) heterogeneously dense, D cup; (2) scattered fibroglandular densities, DD cup; (3) scattered fibroglandular densities, C cup; and (4) scattered fibroglandular
densities, DD cup. Please note that the front surface of the breasts, being pliable, assume the smooth shape of the breast cup.
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FIG. 12. Maximum intensity projections in the coronal projection of bilat-
eral PAM exams of the four healthy volunteers.
smaller diameter transducers elements would have increased
the FOV, but at the expense of contrast sensitivity, and there-
fore was not a viable option. Instead, we chose to change
the manner of scanning the detector array to increase projec-
tion density. We chose to scan the PAM array continuously
in a spiral pattern during data acquisition, rather than rotating
the array about its vertical axis as had been done in our pre-
vious prototype PAT scanner. This new spiral scan protocol
increased the density of projections while simultaneously in-
creasing the FOV. By adjusting the number of projection an-
gles in proportion to the projected area encompassed by the
spiral scan, we were able to maintain contrast sensitivity and
spatial resolution for arbitrarily large fields of view as needed
in breast imaging.
Our dedicated photoacoustic mammography (PAM) scan-
ner now consists of a hemispherical detection aperture that
is translated laterally in a spiral pattern, which permits ac-
quisition of 3D photoacoustic images over a 24-cm lateral
field of view. Using this PAM scanning system, we demon-
strated sufficient contrast-to-noise to visualize a 1-mm, blood-
equivalent target through at least 5.3 cm of an optical scatter-
ing medium that displayed an optical attenuation of 1.1 cm−1.
This optical attenuation is typical of what has been measured
for breast tissue.10, 11 We note that the CNR remained con-
stant through the first 3.0 cm of turbid media before dropping
as the depth increased. The reason for this behavior, we be-
lieve, is the result of the dominance of “streak noise,” which is
proportional to photoacoustic (PA) contrast. The streak noise
is much greater than the electronic noise “floor” of the input
electronics of our data acquisition system at shallow depths,
where PA contrast is highest. As the PAM contrast falls to
lower levels at greater depths, the electronic noise begins to
degrade our CNR, as we have demonstrated in Fig. 9. We esti-
mated the spatial resolution of our PAM scanner as 0.42 mm,
which is only slightly greater than the theoretical minimum
of 0.38 mm (λ/2) due to the 2 MHz transducers used in our
scanner.
We have improved the contrast sensitivity of our previous
photoacoustic detector array by reducing the center frequency
of our transducer from 5 MHz to 2 MHz as we speculated in
our previous work.16 As we then noted, the peak response of
our 5 MHz transducer lay outside the 4.0 MHz passband of
our reconstruction filter and above the predominant, photoa-
coustic temporal frequencies generated by vascular structures
and tumors (>0.5 mm diameter) within the breast. The peak
response of our 2 MHz transducers now better overlaps these
temporal frequencies.
The thickness of the breast tissue was compressed to 2.3–
4.0 cm, depending on the size of the breast being imaged.
The compression was the result of the patient being in the
prone position on the scanning table and not the result of a
compression paddle as used in conventional mammography.
The bilateral breast images demonstrated good vessel visi-
bility throughout the parenchyma of both breasts of all the
volunteers. Contrast equalization (eαz, α = 1.0) successfully
compressed the dynamic range of our PAM so that all ves-
sels could be simultaneously visualized, regardless of depth.
Based on our phantom studies, we expect to be able to im-
age through as much as 5.3 cm of tissue for larger breasts, or
a breast with a volume as large as 1335 mL. This represents
the 90th percentile of breast volumes encountered in clinical
practice in the United States.21
5. CONCLUSION
We have developed a dedicated photoacoustic mammog-
raphy system capable of imaging blood vessels throughout
an entire human breast with submillimeter spatial resolu-
tion. Through upcoming clinical trials, we will evaluate the
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feasibility of PAM in the evaluation of the vascular network
present in both malignant and benign breast lesions.
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